Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma

Clinical trial NCT05535023 · WITHDRAWN

Trial details

NCT number: NCT05535023
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma Oropharynx Cancer Head and Neck Cancer

Start date: 2022-08-24
Primary completion: 2023-07-25
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.